NCT03109470View on ClinicalTrials.gov

The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Rheumatoid Arthritis
Sponsors
All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Pope Research Corporation

INDUSTRY